35 related articles for article (PubMed ID: 16269345)
1. Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo.
Uccelletti D; Zanni E; Marcellini L; Palleschi C; Barra D; Mangoni ML
Antimicrob Agents Chemother; 2010 Sep; 54(9):3853-60. PubMed ID: 20606068
[TBL] [Abstract][Full Text] [Related]
2. Optimal drug synergy in antimicrobial treatments.
Torella JP; Chait R; Kishony R
PLoS Comput Biol; 2010 Jun; 6(6):e1000796. PubMed ID: 20532210
[TBL] [Abstract][Full Text] [Related]
3. Mammalian histones facilitate antimicrobial synergy by disrupting the bacterial proton gradient and chromosome organization.
Doolin T; Amir HM; Duong L; Rosenzweig R; Urban LA; Bosch M; Pol A; Gross SP; Siryaporn A
Nat Commun; 2020 Aug; 11(1):3888. PubMed ID: 32753666
[TBL] [Abstract][Full Text] [Related]
4. The Antistaphylococcal Activity of Citropin 1.1 and Temporin A against Planktonic Cells and Biofilms Formed by Isolates from Patients with Atopic Dermatitis: An Assessment of Their Potential to Induce Microbial Resistance Compared to Conventional Antimicrobials.
Dawgul M; Baranska-Rybak W; Piechowicz L; Bauer M; Neubauer D; Nowicki R; Kamysz W
Pharmaceuticals (Basel); 2016 May; 9(2):. PubMed ID: 27231918
[TBL] [Abstract][Full Text] [Related]
5. Temporins: Multifunctional Peptides from Frog Skin.
D'Andrea LD; Romanelli A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982501
[TBL] [Abstract][Full Text] [Related]
6. Improving the Management and Treatment of Diabetic Foot Infection: Challenges and Research Opportunities.
Turzańska K; Adesanya O; Rajagopal A; Pryce MT; Fitzgerald Hughes D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835330
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of KPC and NDM Klebsiella pneumoniae To Rifampicin by the Human Lactoferrin-Derived Peptide hLF1-11.
Morici P; Rizzato C; Ghelardi E; Rossolini GM; Lupetti A
Microbiol Spectr; 2023 Feb; 11(1):e0276722. PubMed ID: 36537823
[TBL] [Abstract][Full Text] [Related]
8. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.
Jorge P; Grzywacz D; Kamysz W; Lourenço A; Pereira MO
PLoS One; 2017; 12(3):e0174654. PubMed ID: 28355248
[TBL] [Abstract][Full Text] [Related]
9. Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.
Garbacz K; Kamysz W; Piechowicz L
Virulence; 2017 Jan; 8(1):94-100. PubMed ID: 27450039
[No Abstract] [Full Text] [Related]
10. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
Eckert R; Brady KM; Greenberg EP; Qi F; Yarbrough DK; He J; McHardy I; Anderson MH; Shi W
Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
[TBL] [Abstract][Full Text] [Related]
11. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
[TBL] [Abstract][Full Text] [Related]
12. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
Nordmann P; Naas T; Fortineau N; Poirel L
Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
Saiman L
Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; Riva A; Łukasiak J; Scalise G
Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
Oo TZ; Cole N; Garthwaite L; Willcox MD; Zhu H
J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
